Tarbox Family Office’s Novartis NVS Stock Holding History

Tarbox Family Office’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-188	Closed	-$16K	–	697
2022 Q1	$16K	Hold	188	–	–	﹤0.01%	320
2021 Q4	$16K	Hold	188	–	–	﹤0.01%	386
2021 Q3	$15K	Hold	188	–	–	﹤0.01%	424
2021 Q2	$17K	Buy	+188	New	+$16.7K	﹤0.01%	404
2017 Q2	–	Sell	-383	Closed	-$25K	–	599
2017 Q1	$25K	Hold	383	–	–	0.01%	185
2016 Q4	$25K	Hold	383	–	–	0.01%	158
2016 Q3	$27K	Hold	383	–	–	0.02%	143
2016 Q2	$28K	Sell	383 -1,562	-80%	-$108K	0.02%	139
2016 Q1	$126K	Buy	1,945 +1,562	+408%	+$106K	0.1%	69
2015 Q4	$30K	Hold	383	–	–	0.02%	125
2015 Q3	$32K	Buy	+383	New	+$34.1K	0.03%	116
2014 Q4	–	Sell	-1,225	Closed	-$103K	–	574
2014 Q3	$103K	Hold	1,225	–	–	0.09%	72
2014 Q2	$99K	Sell	1,225 -4,507	-79%	-$354K	0.09%	75
2014 Q1	$436K	Buy	5,732 +4,572	+394%	+$333K	0.39%	35
2013 Q4	$83K	Buy	+1,160	New	+$80.6K	0.07%	101

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Tarbox Family Office's NVS Position: Q2 2022 in Review

Tarbox Family Office sold out of Novartis (NVS) in Q2 2022, closing a stake of 188 shares — an estimated $16K sold.

Tarbox Family Office first reported a position in NVS in Q4 2013 and held it in 15 quarters. The position peaked at $436K in Q1 2014. 1,140 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

Tarbox Family Office reported no remaining Novartis position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 188 Novartis shares in Q2 2022, an estimated $16K.
Tarbox Family Office first reported a position in Novartis in Q4 2013 and held it in 15 quarters.
Tarbox Family Office's Novartis position peaked at $436K in Q1 2014.
1,140 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.